NCT03311139View on ClinicalTrials.gov

Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden

CompletedOBSERVATIONAL
Enrollment

14,226

Participants

Timeline

Start Date

November 16, 2017

Primary Completion Date

March 23, 2018

Study Completion Date

March 23, 2018

Conditions
Atrial Fibrillation
Interventions
DRUG

Antithrombotic agents

Antiplatelets and anticoagulants purchased 4 months before and within 7 days after the index date

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

Janssen Research & Development, LLC

INDUSTRY

lead

Bayer

INDUSTRY